Changes in serum and prostatic zinc concentrations in rats after intraprostatic injection of zinc: Comparison of two forms of zinc delivery

International Journal of Urology

Volumn 9, Issue 12, 2002, Pages 681-687

  Cho, Yong Hyun ^a   Lee, Seung Ju ^a   Ji, Youl Lee ^a   Sae, Woong Kim ^a,c   Jung, Ju Kim ^b   Woo, Young Lee ^b   Moon, Soo Yoon ^a  

^a The Catholic University of Korea   (South Korea)

^b AmorePacific Corporation   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Chronic prostatitis; Intraprostatic injection; Rats; Zinc

Indexed keywords

LIPOSOME; WATER; ZINC SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BLOOD CHEMISTRY; CHRONIC PROSTATITIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SOLUTION; DRUG TISSUE LEVEL; HISTOPATHOLOGY; INFLAMMATION; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE; RAT; URINALYSIS; URINE CULTURE;

EID: 0037234113     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2002.00543.x     Document Type: Article

References (32)

1. Vallee BL, Galdes A. The metallobiochemistry of zinc. Adv. Enzymol. Relat. Areas Mol. Biol. 1984; 56: 283-430.
2. Vallee BL. Biochemistry, physiology and pathology of zinc. Physiol. Rev. 1992; 39: 443-90.
3. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol. Rev. 1993; 73: 79-118.
4. Cunningham-Rundles S, Bockman RS, Lin A et al. Physiological and pharmacological effects of zinc on immune response. Ann. NY Acad. Sci. 1990; 587: 113-22.
5. Youmans GP, Leibling J, Lyman RY. The bactericidal action of prostatic fluid in dogs. J. Infect. Dis. 1938; 62: 117-21.
6. Fair WR, Couch J, Wehner N. Prostatic antibacterial factor: Identity and significance. Urology 1976; 7: 169-77.
7. Parrish RF, Perinetti EP, Fair WR. Evidence against a zinc binding peptide in pilocarpine-stimulated canine prostatic secretions. Prostate 1983; 4: 189-93.
8. Korant BD, Kauer JC, Butterworth BE. Zinc ions inhibit replication of rhinoviruses. Nature 1974; 248: 588-90.
9. Katz E, Margalith E. Inhibition of vaccinia virus maturation by zinc chloride. Antimicrob. Agents Chemother. 1981; 19: 213-7.
10. Gib L, Molin L. On the inhibitory activity of human prostatic fluid on Candida albicans. Mykosen. 1970; 13: 61-3.
11. Gardner WA Jr, O'Hara C, Bailey J, Bennett BD. In vitro susceptibility of Trichomonas vaginalis to zinc. Prostate 1981; 2: 323-5.
12. Hanna L, Keshishyan H, Brooks GF, Stites DP, Jawetz E. Effect of seminal plasma on Chlamydia trachomatis strain LB-1 in cell culture. Infect. Immun. 1981; 32: 404-6.
13. Greenberg SB, Harris D, Giles P, Martin RR, Wallace RJ Jr. Inhibition of Chlamydia trachomatis growth in McCoy, HeLa, and human prostate cells by zinc. Antimicrob. Agents Chemother. 1985; 27: 953-7.
14. Fahim MS, Ibrahim HH, Girgis SM, Essa HA, Hanafi S. Value of intraprostatic injection of zinc and vitamin C and of ultrasound application in infertile men with chronic prostatitis. Arch. Androl. 1985; 14: 81-7.
15. Fahim MS, Wang M, Sutcu MF, Fahim Z. Zinc arginine, a 5α-reductase inhibitor, reduces rat ventral prostate weight and DNA without affecting testicular function. Andrologia 1993; 25: 369-75.
16. Costello LC, Franklin RB. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate 1998; 35: 285-96.
17. Jesik CJ, Holland JM, Lee C. An anatomic and histologic study of the rat prostate. Prostate 1982; 3: 81-97.
18. Hamer DH. Metallothionein. Annu. Rev. Biochem. 1986; 55: 913-51.
19. Sorensen MB, Stoltenberg M, Juhl S, Danscher G, Ernst E. Ultrastructural localization of zinc ions in the rat prostate: an autometallographic study. Prostate 1997; 31: 125-30.
20. Ghatak S, Oliveria P, Kaplan P, Ho SM. Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: Lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate. Prostate 1996; 29: 91-100.
21. Fair WR, Heston WD. The relationship of bacterial prostatitis and zinc. Prog. Clin. Biol. Res. 1977; 14: 129-42.
22. Marmar JL, Katz S, Praiss DE, DeBenedictis TJ. Semen zinc levels in infertile and prostatectomy patients and patients with prostatitis. Fertil. Steril. 1975; 26: 1057-63.
23. Anderson RU, Fair WR. Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinoma. Invest. Urol. 1976; 14: 137-40.
24. Orland SM, Hanno PM, Wein AJ. Prostatitis, prostatosis, and prostatodynia. Urology 1985; 25: 439-59.
25. Fischer PW, Giroux A, L'Abbe MR. Effect of zinc supplementation on copper status in adult man. Am. J. Clin. Nutr. 1984; 40: 743-6.
26. Stamey TA, Meares EM Jr, Winningham DG. Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J. Urol. 1970; 103: 187-94.
27. Winningham DG, Stamey TA. Diffusion of antibiotics from plasma into prostatic fluid. Nature 1968; 219: 139-43.
28. Plomp TA, Baert L, Maes RA. Treatment of recurrent chronic bacterial prostatitis by local injection of thiamphenicol into prostate. Urology 1980; 15: 542-7.
29. Jimenez-Cruz JF, Tormo FB, Gomez JG. Treatment of chronic prostatitis: intraprostatic antibiotic injections under echography control. J. Urol. 1988; 139: 967-70.
30. Yamamoto M, Hibi H, Satoshi K, Miyake K. Chronic bacterial prostatitis treated with intraprostatic injection of antibiotics. Scand. J. Urol. Nephrol. 1996; 30: 199-202.
31. Bahk JY, Hyun JS, Lee JY et al. Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin. J. Urol. 2000; 163: 1560-4.
32. Leonard A, Gerber GB, Leonard F. Mutagenicity, carcinogenicity and teratogenicity of zinc. Mutat. Res. 1986;168: 343-53.